Cargando…

A mutation in the iron-responsive element of ALAS2 is a modifier of disease severity in a patient suffering from CLPX associated erythropoietic protoporphyria

Detalles Bibliográficos
Autores principales: Ducamp, Sarah, Luscieti, Sara, Ferrer-Cortès, Xènia, Nicolas, Gaël, Manceau, Hana, Peoc’h, Katell, Yien, Yvette Y., Kannengiesser, Caroline, Gouya, Laurent, Puy, Herve, Sanchez, Mayka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252951/
https://www.ncbi.nlm.nih.gov/pubmed/33596641
http://dx.doi.org/10.3324/haematol.2020.272450
_version_ 1783717406216028160
author Ducamp, Sarah
Luscieti, Sara
Ferrer-Cortès, Xènia
Nicolas, Gaël
Manceau, Hana
Peoc’h, Katell
Yien, Yvette Y.
Kannengiesser, Caroline
Gouya, Laurent
Puy, Herve
Sanchez, Mayka
author_facet Ducamp, Sarah
Luscieti, Sara
Ferrer-Cortès, Xènia
Nicolas, Gaël
Manceau, Hana
Peoc’h, Katell
Yien, Yvette Y.
Kannengiesser, Caroline
Gouya, Laurent
Puy, Herve
Sanchez, Mayka
author_sort Ducamp, Sarah
collection PubMed
description
format Online
Article
Text
id pubmed-8252951
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-82529512021-07-14 A mutation in the iron-responsive element of ALAS2 is a modifier of disease severity in a patient suffering from CLPX associated erythropoietic protoporphyria Ducamp, Sarah Luscieti, Sara Ferrer-Cortès, Xènia Nicolas, Gaël Manceau, Hana Peoc’h, Katell Yien, Yvette Y. Kannengiesser, Caroline Gouya, Laurent Puy, Herve Sanchez, Mayka Haematologica Case Reports Fondazione Ferrata Storti 2021-02-18 /pmc/articles/PMC8252951/ /pubmed/33596641 http://dx.doi.org/10.3324/haematol.2020.272450 Text en Copyright© 2021 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Case Reports
Ducamp, Sarah
Luscieti, Sara
Ferrer-Cortès, Xènia
Nicolas, Gaël
Manceau, Hana
Peoc’h, Katell
Yien, Yvette Y.
Kannengiesser, Caroline
Gouya, Laurent
Puy, Herve
Sanchez, Mayka
A mutation in the iron-responsive element of ALAS2 is a modifier of disease severity in a patient suffering from CLPX associated erythropoietic protoporphyria
title A mutation in the iron-responsive element of ALAS2 is a modifier of disease severity in a patient suffering from CLPX associated erythropoietic protoporphyria
title_full A mutation in the iron-responsive element of ALAS2 is a modifier of disease severity in a patient suffering from CLPX associated erythropoietic protoporphyria
title_fullStr A mutation in the iron-responsive element of ALAS2 is a modifier of disease severity in a patient suffering from CLPX associated erythropoietic protoporphyria
title_full_unstemmed A mutation in the iron-responsive element of ALAS2 is a modifier of disease severity in a patient suffering from CLPX associated erythropoietic protoporphyria
title_short A mutation in the iron-responsive element of ALAS2 is a modifier of disease severity in a patient suffering from CLPX associated erythropoietic protoporphyria
title_sort mutation in the iron-responsive element of alas2 is a modifier of disease severity in a patient suffering from clpx associated erythropoietic protoporphyria
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252951/
https://www.ncbi.nlm.nih.gov/pubmed/33596641
http://dx.doi.org/10.3324/haematol.2020.272450
work_keys_str_mv AT ducampsarah amutationintheironresponsiveelementofalas2isamodifierofdiseaseseverityinapatientsufferingfromclpxassociatederythropoieticprotoporphyria
AT luscietisara amutationintheironresponsiveelementofalas2isamodifierofdiseaseseverityinapatientsufferingfromclpxassociatederythropoieticprotoporphyria
AT ferrercortesxenia amutationintheironresponsiveelementofalas2isamodifierofdiseaseseverityinapatientsufferingfromclpxassociatederythropoieticprotoporphyria
AT nicolasgael amutationintheironresponsiveelementofalas2isamodifierofdiseaseseverityinapatientsufferingfromclpxassociatederythropoieticprotoporphyria
AT manceauhana amutationintheironresponsiveelementofalas2isamodifierofdiseaseseverityinapatientsufferingfromclpxassociatederythropoieticprotoporphyria
AT peochkatell amutationintheironresponsiveelementofalas2isamodifierofdiseaseseverityinapatientsufferingfromclpxassociatederythropoieticprotoporphyria
AT yienyvettey amutationintheironresponsiveelementofalas2isamodifierofdiseaseseverityinapatientsufferingfromclpxassociatederythropoieticprotoporphyria
AT kannengiessercaroline amutationintheironresponsiveelementofalas2isamodifierofdiseaseseverityinapatientsufferingfromclpxassociatederythropoieticprotoporphyria
AT gouyalaurent amutationintheironresponsiveelementofalas2isamodifierofdiseaseseverityinapatientsufferingfromclpxassociatederythropoieticprotoporphyria
AT puyherve amutationintheironresponsiveelementofalas2isamodifierofdiseaseseverityinapatientsufferingfromclpxassociatederythropoieticprotoporphyria
AT sanchezmayka amutationintheironresponsiveelementofalas2isamodifierofdiseaseseverityinapatientsufferingfromclpxassociatederythropoieticprotoporphyria
AT ducampsarah mutationintheironresponsiveelementofalas2isamodifierofdiseaseseverityinapatientsufferingfromclpxassociatederythropoieticprotoporphyria
AT luscietisara mutationintheironresponsiveelementofalas2isamodifierofdiseaseseverityinapatientsufferingfromclpxassociatederythropoieticprotoporphyria
AT ferrercortesxenia mutationintheironresponsiveelementofalas2isamodifierofdiseaseseverityinapatientsufferingfromclpxassociatederythropoieticprotoporphyria
AT nicolasgael mutationintheironresponsiveelementofalas2isamodifierofdiseaseseverityinapatientsufferingfromclpxassociatederythropoieticprotoporphyria
AT manceauhana mutationintheironresponsiveelementofalas2isamodifierofdiseaseseverityinapatientsufferingfromclpxassociatederythropoieticprotoporphyria
AT peochkatell mutationintheironresponsiveelementofalas2isamodifierofdiseaseseverityinapatientsufferingfromclpxassociatederythropoieticprotoporphyria
AT yienyvettey mutationintheironresponsiveelementofalas2isamodifierofdiseaseseverityinapatientsufferingfromclpxassociatederythropoieticprotoporphyria
AT kannengiessercaroline mutationintheironresponsiveelementofalas2isamodifierofdiseaseseverityinapatientsufferingfromclpxassociatederythropoieticprotoporphyria
AT gouyalaurent mutationintheironresponsiveelementofalas2isamodifierofdiseaseseverityinapatientsufferingfromclpxassociatederythropoieticprotoporphyria
AT puyherve mutationintheironresponsiveelementofalas2isamodifierofdiseaseseverityinapatientsufferingfromclpxassociatederythropoieticprotoporphyria
AT sanchezmayka mutationintheironresponsiveelementofalas2isamodifierofdiseaseseverityinapatientsufferingfromclpxassociatederythropoieticprotoporphyria